Holen Sie sich die Stockscreener-App
1.02
18.56%
0.1597
Handel nachbörslich:
1.05
0.03
+2.94%
Schlusskurs vom Vortag:
$0.8603
Offen:
$0.86
24-Stunden-Volumen:
1.36M
Relative Volume:
1.16
Marktkapitalisierung:
$99.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.31M
KGV:
-3.8563
EPS:
-0.2645
Netto-Cashflow:
$-21.07M
1W Leistung:
+9.68%
1M Leistung:
-13.56%
6M Leistung:
+32.11%
1J Leistung:
+12.05%
1-Tages-Spanne:
$0.86
$1.065
1-Wochen-Bereich:
$0.8204
$1.065
52-Wochen-Spanne:
$0.3258
$1.53
Oncolytics Biotech Inc Stock (ONCY) Company Profile
Firmenname
Oncolytics Biotech Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ONCY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ONCY
Oncolytics Biotech Inc
|
1.02 | 83.81M | 0 | -20.31M | -21.07M | -0.2645 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-06 | Eingeleitet | Maxim Group | Buy |
| 2021-02-17 | Eingeleitet | H.C. Wainwright | Buy |
Oncolytics Biotech Inc Aktie (ONCY) Neueste Nachrichten
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders - Eastern Progress
Can Oncolytics Biotech Inc. reach all time highs this yearDaily High ROI Stock Ideas - newsyoung.net
Stocks in play: Oncolytics Biotech Inc - The Globe and Mail
Oncolytics Biotech Inc - Baystreet.ca
Stocks In Play: Oncolytics Biotech Inc - Barchart.com
Is Oncolytics Biotech Inc. a turnaround storyExtreme Return Watchlist - thegnnews.com
Oncolytics Biotech Announces AGM Voting Results - TipRanks
Oncolytics Biotech announces voting results from annual meeting - Investing.com
RBC Capital Keeps Buy Rating on Oncolytics Biotech with $3.50 Price Target - AInvest
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Oncolytics Biotech Advances Pelareorep with Strategic Moves - MSN
Oncolytics Biotech® Announces Voluntary Delisting from the Toronto Stock Exchange - Eastern Progress
Oncolytics Biotech: A High-Conviction Play in the Next-Gen Immunotherapy Space - AInvest
Oncolytics Biotech Advances Pelareorep Clinical Program with Strategic Moves - The Globe and Mail
Oncolytics Biotech Reports Reduced Losses in Q2 2025 Financial Update - The Globe and Mail
(ONC) Strategic Market Analysis (ONC:CA) - news.stocktradersdaily.com
Oncolytics Biotech shares fall 2.73% intraday after announcing voluntary delisting from the Toronto Stock Exchange. - AInvest
Oncolytics Biotech Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Oncolytics Biotech to Delist from TSX, Focus on Nasdaq - TipRanks
Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried? - The Globe and Mail
Oncolytics Biotech's Q2 Loss Narrows: A Strategic Turnaround or a Fleeting Reprieve? - AInvest
Oncolytics Biotech Q2 net loss narrows - MarketScreener
Oncolytics Biotech Files SEC Report Incorporating Information Circular - TipRanks
Oncolytics Biotech reports Q2 highlights, management team updates, and financial results. - AInvest
Oncolytics Biotech to delist from Toronto Stock Exchange By Investing.com - Investing.com South Africa
Oncolytics Biotech to delist from Toronto Stock Exchange - Investing.com
Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep - Barchart.com
Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange - Barchart.com
Oncolytics Biotech Inc. shares fall 1.94% after-hours as stock futures rise and trade negotiations continue. - AInvest
Oncolytics Biotech Inc. shares rise 3.16% premarket as stock futures rise ahead of tariff deadline. - AInvest
Oncolytics Biotech to Hold Virtual Annual Meeting and Announce Q2 Financial Results - TipRanks
Oncolytics Biotech® Announces Upcoming Annual General Meeting and Second Quarter Financial Results - Financial Times
Oncolytics Biotech Inc. stock momentum explainedRisk/Reward Optimization Entry Point Analysis - Newser
Published on: 2025-08-04 08:21:46 - Jammu Links News
Objective long/short (ONC) Report (ONC:CA) - news.stocktradersdaily.com
What are the latest earnings results for Oncolytics Biotech Inc.Build a diversified portfolio for steady growth - Jammu Links News
What analysts say about Oncolytics Biotech Inc. stockUnbelievable profit margins - Jammu Links News
How many analysts rate Oncolytics Biotech Inc. as a “Buy”Exceptional gains - Jammu Links News
What drives Oncolytics Biotech Inc. stock priceOutstanding growth strategies - Jammu Links News
Does Oncolytics Biotech Inc. stock perform well during market downturnsGet timely market insights for better trades - Jammu Links News
When is Oncolytics Biotech Inc. stock expected to show significant growthInvest smarter with expert stock picks - Jammu Links News
What is the risk reward ratio of investing in Oncolytics Biotech Inc. stockBuild wealth with professional market analysis - Jammu Links News
Should I hold or sell Oncolytics Biotech Inc. stock in 2025Unlock powerful trading signals for profits - Jammu Links News
Why is Oncolytics Biotech Inc. stock attracting strong analyst attentionCapitalize on stocks with high profit margins - Jammu Links News
What institutional investors are buying Oncolytics Biotech Inc. stockUnlock expert insights for smarter investing - Jammu Links News
Is it the right time to buy Oncolytics Biotech Inc. stockAchieve rapid financial growth with expert help - Jammu Links News
Is Oncolytics Biotech Inc. a growth stock or a value stockInvest smarter with real-time trading signals - Jammu Links News
What catalysts could drive Oncolytics Biotech Inc. stock higher in 2025Invest smarter with expert stock recommendations - Jammu Links News
What are analysts’ price targets for Oncolytics Biotech Inc. in the next 12 monthsLow Risk Recommendation With High Returns - Jammu Links News
(ONC) Financial Trading Report (ONC:CA) - news.stocktradersdaily.com
Oncolytics Biotech Engages FDA for Pivotal Pancreatic Cancer Study - The Globe and Mail
Finanzdaten der Oncolytics Biotech Inc-Aktie (ONCY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):